Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05376059 · ClinicalTrials.gov registry record · NA

How v. How and Why Nudges and Rewards

A NA study of Control Condition and How Incentive Receive, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
60,000
Enrollment target
1
Study location

NCT05376059 is a NA study of Control Condition and How Incentive Receive that has completed, run by University of Pennsylvania. The registered enrollment target is 60,000 participants, above the 87-participant average among 5 other Control Condition trials with a reported enrollment target (68866% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05376059, a NA study of Control Condition and How Incentive Receive, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
60,000 participants
Enrollment target
1
Study location

Study Summary

Members of CVS/Aetna will receive a direct mailing or receive no outreach at all. Our design will be a 3-cell between-subjects design: 1. control: this will be a group who will not receive any outreach 2. how: this will be a group that will receive a mailer emphasizing only how to seek treatment for mental health issues 3. how and why: this will be a mailer emphasizing both how to get help and why they should get help for mental health issues (i.e., listing out how mental health treatment can improve their lives). Within the how and how and why conditions, participants will be further divided into two different groups: 1. incentive ineligible 2. incentive eligible The incentive ineligible will receive the how or how and why mailer, depending on their condition. For the incentive eligible, they will again further be divided into the following two groups: 1. incentive holdout 2. incentive receive Those randomized into the incentive holdout group will receive the how or how and why mailer, depending on their condition. Those randomized into the incentive receive group will receive one of those two mailers, but it will also include an incentive if they seek out mental health treatment (if they visit a therapist within 30 days, they will receive a gift card).

Interventions

  • BEHAVIORAL Incentive
  • BEHAVIORAL How Nudge
  • BEHAVIORAL How and Why Nudge

Study Locations (1)

Pennsylvania

  • Wharton Marketing Department - Philadelphia

Trial Details

FieldValue
Enrollment Target 60,000 participants
Start Date 2022-04-24
Est. Completion 2023-05-01
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT05376059

The ClinicalTrials.gov registry entry for NCT05376059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 87-participant average among 5 other Control Condition trials with a reported enrollment target (68866% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Control Condition appearing as the primary indexed condition, and to 3 interventions - of which Incentive is the first listed.

NCT05376059 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05376059 about?

NCT05376059 is a clinical study titled "How v. How and Why Nudges and Rewards". Members of CVS/Aetna will receive a direct mailing or receive no outreach at all. Our design will be a 3-cell between-subjects design: 1. control: this will be a group who will not receive any outreach 2. how: this will be a group that will receive a mailer emphasizing only how to seek treatment f...

What is the current status of trial NCT05376059?

This trial is currently completed. It is a NA study. The enrollment target is 60,000 participants. The study started on 2022-04-24. Estimated completion is 2023-05-01.

What conditions does trial NCT05376059 study?

This clinical trial studies the following conditions: Control Condition, How Incentive Receive, How Incentive Holdout, How Incentive Ineligible, How and Why Incentive Receive.

What interventions are being tested in trial NCT05376059?

The interventions under investigation include: Incentive (BEHAVIORAL), How Nudge (BEHAVIORAL), How and Why Nudge (BEHAVIORAL).

Who is sponsoring clinical trial NCT05376059?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05376059 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Control Condition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.